Mehrukh Zehravi | Toxicology and Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Dr. Mehrukh Zehravi | Toxicology and Pharmaceutical Science | Best Researcher Award

Buraydah Private colleges, Saudi Arabia

She is a highly motivated and experienced Clinical Pharmacy lecturer with a proven track record of delivering engaging and effective teaching to both undergraduate and graduate students. With in-depth knowledge of Clinical Pharmacy, therapeutics, medication management, patient counseling, and drug safety, she excels in developing and delivering curricula, supervising practical training sessions, and conducting research to advance the field of clinical pharmacy. She collaborates effectively with other healthcare professionals to improve patient care and outcomes. A passionate and dedicated educator, she is committed to providing students with the knowledge and skills they need to succeed in their careers as pharmacists.

Professional Profile

Education

She is currently pursuing a Ph.D. in Pharmaceutical Sciences at the University of Karachi, Pakistan, expected to complete in 2025. She holds a Master’s in Pharmaceutical Sciences, earned between August 2007 and December 2009, and a Bachelor of Pharmacy, completed between January 2002 and December 2005, both from the University of Karachi. Throughout her career, she has received a letter of appreciation from the University for her on-field Pharmacy Training from 2016 to 2023. She designed and implemented a new clinical pharmacy curriculum that enhanced student learning and engagement, leading to improved student performance and feedback. She has published multiple research articles in high-impact, peer-reviewed journals, demonstrating her expertise in clinical pharmacy and contributing to the field’s advancement. Additionally, she has mentored and supervised graduate students in clinical pharmacy research, helping them develop their research skills and publish their work in reputable journal

Professional Experience

She has actively participated in various conferences and workshops to enhance her professional development. In 2016, she attended a workshop on “Coaching Conversation Approaches for the Workplace” at Prince Sattam Bin Abdul Aziz University. She also participated in the conference on “WHO Prescribing Indicators & Its Compliance by General Practitioners of Lahore, Pakistan,” conducted by the 4th China Pharmaceutical University International Students Academic Forum at the Conference Center Jiangning Campus in April 2017. She attended the PPA International Conference Seminar on “Pharmacists Voice: Patient Safety Starts with Me” at the University of Central Punjab, Pakistan. Additionally, she was involved in the 3rd Annual Conference of Rashid Latif College of Pharmacy, held at Rashid Latif Medical College, University of Health Sciences, Lahore, Pakistan. She also took part in the “Perspective & Dimensions of Drug Product Bioequivalence in the 21st Century” event, organized by the University of Karachi in December 2015

CONFERENCES & WORKSHOPS

She has actively participated in various conferences and workshops to enhance her professional development. In 2016, she attended a workshop on “Coaching Conversation Approaches for the Workplace” at Prince Sattam Bin Abdul Aziz University. She also participated in the conference on “WHO Prescribing Indicators & Its Compliance by General Practitioners of Lahore, Pakistan,” conducted by the 4th China Pharmaceutical University International Students Academic Forum at the Conference Center Jiangning Campus in April 2017. She attended the PPA International Conference Seminar on “Pharmacists Voice: Patient Safety Starts with Me” at the University of Central Punjab, Pakistan. Additionally, she was involved in the 3rd Annual Conference of Rashid Latif College of Pharmacy, held at Rashid Latif Medical College, University of Health Sciences, Lahore, Pakistan. She also took part in the “Perspective & Dimensions of Drug Product Bioequivalence in the 21st Century” event, organized by the University of Karachi in December 2015

CITATIONS RESEARCH GATE

  • Research Interest Score – 1151
  • Citations –  1508
  • h-Index –    23

CITATION GOOGLE SCHOLAR:

  • Citations –   1516
  • h- Index –      22
  • i-10 Index –    47

Book Chapters:

  1. F Islam, MR Islam, MH Nafady, M Faysal, SL Khan, M Zehravi, Pharmacogenomics of immunosuppressants, Publisher: Elsevier Inc. Pharmacogenomics, 323-344, 2023/11. Academic Press
  2. Karthika, C. et al. (2023). The Role of Curcumin as an Anti-Aging Compound. In: Rizvi, S.I. (eds) Emerging Anti-Aging Strategies. Online 31st January 2023, Springer, Singapore.
  3. Entitled – Basic Laboratory Methods of Pharmacology & Toxicology, Published in Sept 2021, ISBN-976-81-7622-495
  4. C Karthika, M Zehravi, R Akter, MH Rahman, Stretegic design of Nano carrier system for Nutraceutical, CRC Press, Handbook of Nanotechnology in Nutraceuticals, 79-96
  5. Entitled – Pharmacophore Modelling & its significance in Drug Discovery, CRC Press Nanotechnology in Nutraceuticals, Feb 2022, Accepted by the Editor, accepted for the publication.

Publications Top Noted

 

Junjie Liu | pharmaceutics | Best Researcher Award

Posted on by ScienceFather

Prof. Junjie Liu | pharmaceutics | Best Researcher Award

professor, Zhengzhou University, China

Liu Junjie is a professor and PhD supervisor at the School of Pharmacy, Zhengzhou University. 🎓 He completed his PhD in pharmaceutical sciences from Chongqing University in 2018. 📚 With over 40 publications in top journals like Sci Adv and Adv Mater, he is a recognized leader in his field. 🧬 He has led 10 major research projects, including grants from the National Natural Science Foundation of China. 🌍 Liu has received multiple prestigious honors, including youth talent support and high-level talent awards. 🚀 His contributions in pharmaceutical science are shaping the future of health and medicine.

Profile

Education🎓 

Liu Junjie obtained his PhD in pharmaceutical sciences from Chongqing University in 2018. 🏫 His advanced training in pharmaceutical sciences allowed him to develop expertise in drug development and pharmaceutical research. 📑 His education combined rigorous theoretical knowledge and hands-on experience in the laboratory, equipping him with the tools necessary for groundbreaking research. 🧪 He also pursued further professional development through leading postdoctoral research, continuously building on his PhD training. 💡 His academic foundation serves as the cornerstone for his innovative work in drug discovery and therapeutic development.

Experience🧑‍🏫 

Liu Junjie is currently a professor and PhD supervisor at Zhengzhou University’s School of Pharmacy. 🔬 He has extensive experience leading pharmaceutical research and managing collaborative research projects. 🧑‍🔬 Since completing his PhD, he has overseen 10 major research projects, including those supported by the National Natural Science Foundation of China. 🌟 His work has been featured in over 40 SCI-indexed publications as the first or corresponding author, showcasing his strong research output. 🌿 Liu is also actively involved in mentorship, guiding PhD students and shaping the next generation of pharmaceutical scientists.

Awards and Honors🏆

Liu Junjie has received numerous prestigious awards for his contributions to pharmaceutical research. 🎖️ Notably, he has been recognized by the China Association for Science and Technology with the Youth Talent Support award. 🌟 His high-level talent and innovative contributions to the field have earned him recognition in Henan Province, where he received the High-level Talent Award and was named an Outstanding Youth Talent in the Central Plains. 💼 Additionally, he was awarded the Innovative Talent Award for his role in advancing pharmaceutical research at Henan’s Higher Education Institutions.

Research Focus🔬 

Liu Junjie’s research focuses on the development of innovative drugs and therapeutic treatments. 🧪 His work aims to bridge the gap between basic pharmaceutical sciences and clinical applications, exploring drug delivery systems and novel therapeutic materials. 🧬 He is particularly interested in precision medicine and the design of targeted therapies to improve treatment efficacy and minimize side effects. 🌍 His interdisciplinary research integrates chemistry, biology, and materials science to advance drug development, leading to over 40 high-impact publications in renowned scientific journals. 📈 His research aims to transform healthcare and patient outcomes.

Publication Top Notes

In situ implantable DNA hydrogel for diagnosis and therapy of postoperative rehemorrhage following intracerebral hemorrhage surgery

Published in: Science Advances (2024, 10(33), ado3919)
Authors: Yu, W., Gong, E., Wang, C., Liu, J., Shi, J.
Overview: This research focuses on a DNA hydrogel that can be implanted in situ to diagnose and treat rehemorrhage after intracerebral hemorrhage surgery, providing a new tool for post-surgical care.

2. In situ formation of biohybrid system based on Streptococcus pneumoniae for enhanced radical therapy against tumors

Published in: Cell Reports Physical Science (2024, 5(7), 102074)
Authors: Zhao, X., Wang, Q., Dong, H., Liu, J., Shi, J.
Overview: The study explores a biohybrid system using Streptococcus pneumoniae for improved radical cancer therapies, targeting tumors more effectively.

3. Retraction Note: Copper-based metal-organic framework impedes triple-negative breast cancer metastasis via local estrogen deprivation and platelets blockade

Published in: Journal of Nanobiotechnology (2024, 22(1), pp. 302)
Authors: Wang, S., Yin, N., Li, Y., Si, P., Liu, J.
Overview: This article was retracted, but it originally examined how copper-based frameworks prevent breast cancer metastasis by blocking estrogen and platelets.

4. A Neutrophil Hijacking Nanoplatform Reprograming NETosis for Targeted Microglia Polarizing Mediated Ischemic Stroke Treatment

Published in: Advanced Science (2024, 11(17), 2305877)
Authors: Yin, N., Wang, W., Pei, F., Wang, Z.-H., Liu, J.
Overview: The research proposes a nanoplatform that hijacks neutrophils to treat ischemic stroke by modulating microglia polarization.

5. Ultrasensitive Optical Detection and Elimination of Residual Microtumors with a Postoperative Implantable Hydrogel Sensor for Preventing Cancer Recurrence

Published in: Advanced Materials (2024, 36(14), 2307923)
Authors: Geng, S., Guo, P., Wang, J., Shi, J., Liu, J.
Overview: This article focuses on an optical sensor integrated with a hydrogel to detect and remove microtumors post-surgery, reducing cancer recurrence risk.

6. Biomimetic Nanovehicle-Enabled Targeted Depletion of Intratumoral Fusobacterium nucleatum Synergizes with PD-L1 Blockade against Breast Cancer

Published in: ACS Nano (2024, 18(12), pp. 8971–8987)
Authors: Geng, S., Guo, P., Li, X., Liu, J., Yang, Y.
Overview: This study examines a nanovehicle that targets Fusobacterium nucleatum within tumors to boost the effectiveness of PD-L1 blockade therapies for breast cancer.

Conclusion

Liu Junjie is an excellent candidate for the Best Researcher Award. His robust academic output, leadership in research projects, mentorship, and numerous recognitions make him well-suited for this prestigious recognition. While expanding his international collaborations and increasing the practical application of his research could further enhance his candidacy, his contributions to pharmaceutical sciences and his leadership in innovative research projects make him a strong contender for this award.

 

Ricardo Menegatti | Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Ricardo Menegatti | Pharmaceutical Science | Best Researcher Award

Associate Professor and UFG, Brazil

Assoc. Prof. Dr. Ricardo Menegatti is an Associate Professor at the Faculty of Pharmacy, Federal University of Goiás (UFG), Brazil. His academic journey began with a Bachelor’s degree in Pharmacy from the Federal University of Santa Catarina (UFSC), followed by a Master’s degree in Chemistry and a Ph.D. in Chemistry from the Federal University of Rio de Janeiro (UFRJ). His doctoral research focused on the design, synthesis, and pharmacological evaluation of novel neuroactive drug prototypes. Dr. Menegatti’s expertise spans various aspects of medicinal chemistry, including the development of new pharmacological agents, medicinal chemistry, and pharmaceutical analysis. He has been actively involved in teaching and research since joining UFG in 2006, where he has contributed to the development of courses in medicinal chemistry, pharmaceutical analysis, and organic chemistry. His work also includes extensive contributions to the university’s extension activities, such as coordinating workshops and seminars on pharmaceutical chemistry. Dr. Menegatti has a robust record of publications and presentations in his field, and his research interests primarily revolve around the synthesis of novel pharmacological agents and the application of advanced chemical techniques in drug development.

Profile
Education

Dr. Ricardo Menegatti holds a distinguished educational background in the field of pharmacy and chemistry. He earned his Bachelor’s degree in Pharmacy from the Federal University of Santa Catarina (UFSC) in 1998, where his research focused on leprosy. He then pursued advanced studies at the Federal University of Rio de Janeiro (UFRJ), obtaining a Master’s degree in Chemistry in 2001. His master’s research, under the guidance of Eliezer Jesus Barreiro, involved the design, synthesis, and pharmacological evaluation of new antipsychotic drug candidates, specifically targeting schizophrenia. Dr. Menegatti further advanced his expertise by completing a Ph.D. in Chemistry at UFRJ in 2005, focusing on the planning, synthesis, and pharmacological assessment of neuroactive drug prototypes, particularly in the areas of GABA, hypnotics, and analgesics. His doctoral research, also mentored by Eliezer J. Barreiro, was supported by the National Council for Scientific and Technological Development (CNPq), reflecting his commitment to advancing pharmaceutical sciences.

Professional Experience

Dr. Ricardo Menegatti is a seasoned academic and researcher with a strong background in pharmaceutical chemistry and medicinal compounds. He holds a Doctorate in Chemistry from the Federal University of Rio de Janeiro, where his research focused on the design, synthesis, and pharmacological evaluation of neuroactive drug prototypes. Dr. Menegatti currently serves as a Professor at the Faculty of Pharmacy, Federal University of Goiás, Brazil, where he has been a dedicated faculty member since 2006. His expertise lies in planning and synthesizing biologically active compounds, particularly those targeting neuroactive and antipsychotic pathways. In addition to his teaching responsibilities, Dr. Menegatti is actively involved in graduate-level mentoring, guiding students in the Biological Sciences postgraduate program. His contributions extend to organizing workshops, coordinating seminars, and participating in extension activities, reflecting his commitment to advancing pharmaceutical education and research.

Research Interests

Dr. Ricardo Menegatti’s research interests lie at the intersection of pharmaceutical chemistry and medicinal chemistry, with a particular focus on the design, synthesis, and pharmacological evaluation of biologically active compounds. His work primarily revolves around the development of neuroactive drug prototypes, targeting the GABAergic system to explore potential treatments for neurological disorders such as schizophrenia, anxiety, and sleep disorders. Additionally, Dr. Menegatti is engaged in the discovery of new analgesic and antipsychotic agents, leveraging his expertise in molecular modeling and structure-activity relationships (SAR) to enhance drug efficacy and safety. His research also extends to the use of solid-phase synthesis and enzymatic catalysis in drug development, aiming to innovate in the creation of new therapeutic agents. Through his work, Dr. Menegatti contributes to the advancement of medicinal chemistry, striving to address critical challenges in the treatment of mental health disorders.

Awards and Recognition

Dr. Menegatti’s academic and research excellence has been recognized through various awards and honors throughout his career. As a recipient of scholarships from the National Council for Scientific and Technological Development (CNPq) in Brazil, he has demonstrated a strong commitment to advancing scientific knowledge. His leadership in organizing workshops and seminars further highlights his contributions to the academic community, earning him recognition among his peers and students.

Conclusion

Dr. Ricardo Menegatti’s extensive research contributions in medicinal chemistry, particularly in the development of neuroactive and antipsychotic drug candidates, make him a strong candidate for the Research for Best Researcher Award. His work has a significant geographic impact, with potential applications in global healthcare. While his research is primarily focused on pharmaceutical sciences, its implications extend to broader areas such as infectious diseases. Dr. Menegatti’s collaborative efforts, applied research, and academic leadership further solidify his suitability for this prestigious award.

Publications Top Notes

LQFM289: Electrochemical and Computational Studies of a New Trimetozine Analogue for Anxiety Treatment

  • Journal: International Journal of Molecular Sciences
  • Date: September 26, 2023
  • DOI: 10.3390/ijms241914575

Bioanalytical LC-QTOF/MS Method for a N-phenylpiperazine Derivate (LQFM05): An Anxiolytic- and Antidepressant-like Prototype Drug Applied to Pharmacokinetic and Biodistribution Studies

Antileishmanial Activity of the Chalcone Derivative LQFM064 Associated with Reduced Fluidity in the Parasite Membrane as Assessed by EPR Spectroscopy

Toxico-Pharmacological Evaluations of the Small-Molecule LQFM166: Inducer of Apoptosis and MDM2 Antagonist

 

Prof. Ashish Kumar Tewari | Medicinal Chemistry | Best Research Award

Posted on by ScienceFather

Prof. Ashish Kumar Tewari | Medicinal Chemistry | Best Research Award

Professor at Medicinal Chemistry, Department of Chemistry Institute of Science Banaras Hindu University Varanasi 221005 INDIA

👨‍🎓He remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.

🔬 He successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.

🏆 The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.

Professional Profiles:

Education:

Prof. Ashish Kumar Tewari holds a Ph.D. in Synthetic Organic Chemistry from Lucknow University, Lucknow, India, awarded in 2000. He completed his M.Sc. in Organic Chemistry from Kanpur University, with studies at F. G. College Raebareli, in 1993. His undergraduate degree, a B.Sc. in Chemistry and Physics, was obtained from Lucknow University (BSNV Degree College) in 1991.

Research Work:

Prof. Ashish Kumar Tewari is currently an Associate Professor in the Department of Chemistry at Banaras Hindu University, Varanasi, India. His research focuses on Molecular Recognition and Medicinal Chemistry. His work involves synthesizing bioactive molecules, flexible molecules with aromatic backbones, and foldamers to study aromatic interactions. Since approximately 20% of amino acids are aromatic, understanding aromatic interactions is crucial in drug-receptor interactions. His research group is actively involved in synthesizing pyrazole, imidazole, pyridine, and pyridazine systems, yielding interesting results such as solid-state eclipsed and staggered stacked conformations. Their work is reflected in their publications, with ongoing research yet to be published.

Post Doctoral Research Work:

During his postdoctoral research, Prof. Ashish Kumar Tewari worked at the Central Drug Research Institute (CDRI) in Lucknow, UP, India, as a CSIR Research Associate. His project focused on “Stereochemical control in aliphatic compounds by aromatic residues,” involving the synthesis of Pyrazolo[3,4-d]pyrimidine. This compound is isomeric to purine found in biological systems and serves as a model to study intra- and inter-molecular interactions important in drug-receptor interactions. He also worked as a Research Associate at the Indian Institute of Technology (IIT) in Mumbai, India, in the Department of Chemistry. His research there involved synthesizing monomers like triacytelene to prepare polydiacytelenes with aromatic backbones such as quinoline. This process included Suzuki coupling reaction followed by hydrolysis, leading to solid-state polymerization initiated thermally, photochemically, or by γ-irradiation. Recent interest in polydiacytelenes (PDAs) lies in their large and fast non-linear optical response, making them promising for applications in ultrafast optical signal processing.

Teaching Professional Work:

Prof. Ashish Kumar Tewari has held various positions in academia and the pharmaceutical industry. Since June 14, 2019, he has been serving as a Professor in the Department of Chemistry at Banaras Hindu University (BHU) in Varanasi, a Central University in India. Prior to this role, from June 14, 2016, to June 13, 2019, he was an Associate Professor in the same department, with a pay scale of Rs. 37400-67000/- plus AGP Rs. 9000. Before that, from June 14, 2004, to June 13, 2016, he served as an Assistant Professor (Senior Grade) at BHU, with a pay scale of Rs. 15600-39100/- plus AGP Rs. 7000. In these academic positions, his responsibilities included teaching undergraduate (UG) and postgraduate (PG) classes, as well as conducting research. Prior to his academic career, from September 3, 2003, to June 11, 2004, he worked as a Research Scientist at Lupin Research Park, a pharmaceutical industry research center, where he was involved in research activities.

Publications:

  1. Relationship between structure and inhibition behaviour of quinolinium salts for mild steel corrosion: Experimental and theoretical approach
    • Authors: MMS Punita Mourya, Praveen Singh, A.K. Tewari, R.B. Rastogi
    • Journal: Corrosion Science
    • Volume: 95
    • Pages: 71-87
    • Year: 2015
    • Citations: 195
  2. Synthesis and anti-inflammatory activities of N4, N5-disubstituted-3-methyl-1H-pyrazolo [3, 4-c] pyridazines
    • Authors: AK Tewari, A Mishra
    • Journal: Bioorganic & medicinal chemistry
    • Volume: 9
    • Issue: 3
    • Pages: 715-718
    • Year: 2001
    • Citations: 188
  3. Emerging trends in molecular recognition: utility of weak aromatic interactions
    • Authors: AK Tewari, R Dubey
    • Journal: Bioorganic & Medicinal Chemistry
    • Volume: 16
    • Issue: 1
    • Pages: 126-143
    • Year: 2008
    • Citations: 139
  4. Synthesis and antiviral activities of N-substituted-2-substituted-benzimidazole derivatives
    • Authors: AK Tewari, A Mishra
    • Source: CSIR
    • Year: 2006
    • Citations: 132
  5. Synthesis, biological evaluation and molecular modeling study of pyrazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents
    • Authors: AK Tewari, VP Singh, P Yadav, G Gupta, A Singh, RK Goel, P Shinde, …
    • Journal: Bioorganic chemistry
    • Volume: 56
    • Pages: 8-15
    • Year: 2014
    • Citations: 94
  6. Design, synthesis, docking and anti-inflammatory evaluation of novel series of benzofuran based prodrugs
    • Authors: P Yadav, P Singh, AK Tewari
    • Journal: Bioorganic & medicinal chemistry letters
    • Volume: 24
    • Issue: 10
    • Pages: 2251-2255
    • Year: 2014
    • Citations: 82
  7. Novel anti-inflammatory agents based on pyrazole based dimeric compounds; design, synthesis, docking and in vivo activity
    • Authors: AK Tewari, P Srivastava, VP Singh, A Singh, RK Goel, CG Mohan
    • Journal: Chemical and Pharmaceutical Bulletin
    • Volume: 58
    • Issue: 5
    • Pages: 634-638
    • Year: 2010
    • Citations: 71
  8. Quantum chemical calculation studies for interactions of antiwear lubricant additives with metal surfaces
    • Authors: V Jaiswal, RB Rastogi, JL Maurya, P Singh, AK Tewari
    • Journal: RSC Advances
    • Volume: 4
    • Issue: 26
    • Pages: 13438-13445
    • Year: 2014
    • Citations: 35
  9. Docking, synthesis and evaluation of antioxidant activity of 2, 4, 5-triaryl imidazole
    • Authors: P Singh, R Kumar, S Tiwari, RS Khanna, AK Tewari, HD Khanna
    • Journal: Clin. Med. Biochem. Open Access
    • Volume: 1
    • Pages: 105
    • Year: 2015
    • Citations: 34
  10. Cascade synthesis of 2-pyridones using acrylamides and ketones
    • Authors: SK Rai, S Khanam, RS Khanna, AK Tewari
    • Journal: RSC Advances
    • Volume: 4
    • Issue: 83
    • Pages: 44141-44145
    • Year: 2014
    • Citations: 30

 

 

Assoc Prof Dr. Shimaa Ramadan Emam | Pharmacology | Scientific Excellence Achievement Award

Posted on by ScienceFather

Assoc Prof Dr. Shimaa Ramadan Emam | Pharmacology | Scientific Excellence Achievement Award

Pharmacology at , Cairo university, Egypt

👨‍🎓She remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.

🔬 She successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.

🏆 The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.

Professional Profiles:

Education:

Assoc Prof Dr. Shimaa Ramadan Emam has completed a Bachelor of Veterinary Medicine (BVM) in May 2008 from the Faculty of Veterinary Medicine at Cairo University, Egypt, with a very good honor grade. Additionally, they obtained a Master of Sciences (M.S.) in Pharmacology from the Department of Veterinary Pharmacology at Cairo University, Egypt, in May 2011. Their master’s dissertation was titled “Pharmacological studies on Silybum marianum and Marjorana hortensis plants.” They have also completed various courses with excellent grades, including Physiology, Metabolism, and Energy (0028), Special Bacteriology (0073), Advanced Biostatistics (00192), Methods of Research (00800), and Veterinary Pharmacology (0090).

Professional Experience:

Assoc Prof Dr. Shimaa Ramadan Emam has been an Associate Lecturer of Pharmacology at the Faculty of Veterinary Medicine, Cairo University, since 2020. Prior to this, they served as a Lecturer of Pharmacology at the same institution from 2015 to 2020. From 2008 to 2015, they worked as a Research and Teaching Assistant at the Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt. Additionally, they held the position of Demonstrator at the Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt, from 2007 to 2008.

Webinarand Conferences:

The 7th International Conference of the Faculty of Veterinary Medicine, Cairo University (VETCU 2018), which focused on “One Health: Animal, Human, Environment Recent Applications,” held from August 5th to 8th, 2018. They were involved in attendance, participation, and organization of the event. A webinar titled “Enhance Your Research with Elsevier: Discover Research Metrics on and Updated Citescore and Quartiles.” A regional conference on the implementation of international research animal care practices, which took place in Cairo, Egypt, from April 22nd to 24th, 2018. The International Egyptian CZECH Conference on Nanotechnology Applications held at Cairo University on October 10th and 11th, 2017. A webinar focusing on novel approaches in pharmaceutical sciences researches confronting COVID-19, specifically addressing natural products for pandemic control. The 65th Annual Conference of the Egyptian Society of Pharmacology and Experimental Therapeutics (ESPET), which included a workshop on behavioral pharmacology held at the British University in Egypt on January 28th, 2017.

Conferences:

Assoc Prof Dr. Shimaa Ramadan Emam attended the 6th scientific conference, “A Healthy Animal for a Safe Diet,” in Cairo – Hurghada from August 27th to 31st, 2013. They also participated in the 8th scientific conference, “Animal Health, Poultry & Community Health,” held in Cairo – Hurghada from August 23rd to 27th, 2016.

Research Interest:

Pharmacological evaluation of newly synthesized chemical compounds. Pharmacological screening of medicinal plants. Microbiological screening of plant extracts. Biological activity-guided separation and isolation of bioactive compounds from plants using different chemical and chromatographic techniques. Studying drug-drug interactions and drug-herb interactions.

Skills and Techniques:

Assoc Prof Dr. Shimaa Ramadan Emam has significant experience in using various statistical programs, such as SPSS and pharmacokinetic programs. They also possess a wide range of technical skills, including expertise in techniques like High-Performance Liquid Chromatography (HPLC), High-Performance Liquid Chromatography Mass Spectrophotometry (HPLC-MS), Microbiological Assay, Spectrophotometry, and Ultrasonography. Moreover, they are familiar with planning and have technical expertise in executing in vivo protocols to conduct studies. This includes tasks like in vivo dosing and sample preparation for analysis, in vivo disease model development, scheduling and overseeing Pharmacokinetic (PK) studies, and analyzing results. Additionally, they are proficient in preparing detailed experimental records, summaries, and technical reports.

Language Skills:

Assoc Prof Dr. Shimaa Ramadan Emam is fluent in Arabic, their mother tongue, and possesses excellent reading and writing skills in both Arabic and English. They are proficient in using computer software, including Microsoft Office (Word, Excel, PowerPoint), Photoshop, and Adobe Acrobat. Their experience with these programs indicates a strong familiarity with computer writing skills.

Awards Special Experience:

Assoc Prof Dr. Shimaa Ramadan Emam  has received international publication awards from Cairo University in both 2020 and 2021. They are experienced in planning and executing in vivo protocols, conducting studies such as in vivo dosing and sample preparation for analysis, developing in vivo disease models, scheduling and overseeing pharmacokinetic (PK) studies, and analyzing the results. Additionally, they are skilled in preparing detailed experimental records, summaries, and technical reports.

Publications:

Optimization of an Off-Grid PV/Biomass Hybrid System with Different Battery Technologies

  • Published in Energy in 2018 with 197 citations.

A flower pollination optimization algorithm for an off-grid PV-Fuel cell hybrid renewable system

  • Published in Energy in 2019 with 179 citations.

Multi-Objective Optimization of Grid-Connected PV-Wind Hybrid System Considering Reliability, Cost, and Environmental Aspects

  • Published in Energy in 2020 with 165 citations.

Techno-economic analysis for rustic electrification in Egypt using multi-source renewable energy based on PV/ wind/ FC

  • Published in Energy in 2020 with 144 citations.

Optimal economic study of hybrid PV-wind-fuel cell system integrated to unreliable electric utility using hybrid search optimization technique

  • Published in Energy in 2021 with 128 citations.

Multi-objective optimization of hybrid renewable energy system based on biomass and fuel cells

  • Published in Energy in 2021 with 66 citations.

A Techno-Economic Feasibility Analysis of an Autonomous Hybrid Renewable Energy Sources for University Building at Saudi Arabia

  • Published in Energy in 2020 with 63 citations.

Feasibility Study of Grid Connected PV-Biomass Integrated Energy System in Egypt

  • Published in Energy in 2016 with 62 citations.

 

Dr. Marta Miarons | Farmacocinética | Young Scientist Award

Posted on by ScienceFather
Dr. Marta Miarons : Leading Researcher in Farmacocinética 

Head of the Pharmacy Service at Farmacocinéticay farmacogenética, Consorci Hospitalari de Vic, Spain

she remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.

🔬 she successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.

🏆 The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.

Professional Profiles:

Education:

Graduating in Pharmacy in 2013, she pursued a specialization in Hospital Pharmacy at Mataró Hospital, where she earned the title of specialist and received the Best Hospital Pharmacy Resident award from the Spanish Society of Hospital Pharmacy in 2018. Simultaneously, she pursued doctorate and was honored with an extraordinary award. shejourney in academia began as an associate professor at the University of Vic – Central University of Catalonia, where she continue to teach to this day. Since May 2023, she have held the role of territorial manager of Pharmacy Services at Hospital Universitari de Vic and Hospital de Campdevànol. Throughout she career, she have remained committed to advancing clinical research, particularly in the areas of pharmacokinetics, pharmacogenetics, and personalized medicine, both nationally and internationally, in the face of high competition.

Position:

  1. Hospital Universitario Vall d’Hebron
    • Position: Farmacéutico especialista
    • Start Date: 15/06/2019
  2. Hospital de Mataró
    • Position: Farmacéutica especialista en Farmacia Hospitalaria
    • Start Date: 21/05/2018
  3. Universitat de Vic
    • Position: Profesor asociado – Facultad de Medicina
    • Start Date: 01/10/2018
Experience supervising:
  1. Project Title: Estudio descriptivo de la farmacocinética de fludarabina en pacientes con quimioterapia linfodeplectiva previa a la infusión de terapia de células T con receptor de antígeno quimérico (CAR-T)
    • Entity: Universitat Autònoma de Barcelona
    • Student: Javier Varela González Aller
  2. Project Title: Estudio prospectivo de la actividad multidisciplinar de la monitorización farmacocinética proactiva de infliximab y adalimumab en pacientes pediátricos con enfermedad inflamatoria intestinal
    • Entity: Universitat Autònoma de Barcelona
    • Student: Susana Clemente Bautista

 

Mr. Asif Nawaz | Pharmacology

Posted on by ScienceFather
Mr. Asif Nawaz : Leading Researcher in Pharmacology by Best Researcher Award

Student at Pharmacology, GC University, Lahore, Pakistan

Your remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.

🔬 Your successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.

🏆 The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.

Professional Profiles:

Education:

The user has a Master of Philosophy (M.Phil.) in Pharmaceutical Sciences with 1st Division from the University of Malakand, Chakdara Dir (Lower), Pakistan, completed from 2019 to 2022. They also hold a Bachelor of Doctor of Pharmacy (Pharm-D) with 1st Division from the University of Malakand, Chakdara Dir (Lower), Pakistan, completed from 2013 to 2018. Additionally, they completed their Intermediate (HSSC – F.Sc Pre-Medical) with 1st Division from Islamia College Peshawar, Pakistan, from 2010 to 2013, and their Matriculation (SSC – Science) with 1st Division from Swat Public School & College, Swat, Pakistan, from 2008 to 2010. Their Pharmacy Council of Pakistan Registration No. is 5397-A/2019.

Conferences and Seminars:

Seminar on “Navigating the future of community pharmacy in Pakistan” organized by NURTURING COMMUNITY PHARMACY at the University of Peshawar, Pakistan, on October 5th, 2015. National conference on “PLANTS: FROM FOOD TO PHYTOMEDICINE” jointly organized by the University of Malakand and the University of Sargoda on May 3-4, 2018. National conference on “PHYTOMEDICINES: CURRENT & FUTURE PERSPECTIVES” jointly organized by Shaheed Benazir Bhutto University, Sheringal, and the University of Malakand on October 9-11, 2018.

Asif Nawaz ‘s citation metrics and indices from Google Scholar are as follows:

  • Cited by: All: 119, Since 2018: 119
  • Citations: 119 (All), 119 (Since 2018)
  • h-index: 8 (All), 8 (Since 2018)
  • i10-index: 5 (All), 5 (Since 2018)

These metrics showcase the impact of Nawaz ‘s work within the academic community, demonstrating the number of citations his publications have received and the influence of his research output.

Certificates and Awards:

  • Participation certificate from Nurturing Community Pharmacy in Pakistan.
  • Conference Organizer certificate for “National conference on plants” from the University of Malakand.
  • Participation certificate from the Expanded Program on Immunization (EPI), BHU Sigram Swat.
  • Commendation certificate from SPS College Swat, Pakistan.

Professional Experience:

  • Visiting Lecturer at Kabal Institute of Medical Sciences (KIMS), Aligrama Swat.
  • Visiting Lecturer at Shifa College of Pharmacy, Thana, Malakand.
  • Quality Control Analyst at Polyfine Chempharma, Hayatabad Peshawar.
  • Two months Volunteer internship at Lady Reading Hospital, Pharmacy Department Peshawar as a trainee pharmacist.
  • Trainee Pharmacist (From 16 July to 18 September 2018) at Saidu Group of Teaching Hospitals, Saidu Sharif, Swat.

Publications:

Underlying anticancer mechanisms and synergistic combinations of phytochemicals with cancer chemotherapeutics: potential benefits and risks

  • Published in Energy in 2022 with 22 citations.

Synthesis, molecular docking and enzyme inhibitory approaches of some new chalcones engrafted pyrazole as potential antialzheimer, antidiabetic and antioxidant agents

  • Published in Energy in 2022 with 15 citations.

HPLC-DAD phenolics analysis, α-glucosidase, α-amylase inhibitory, molecular docking and nutritional profiles of Persicaria hydropiper L.

  • Published in Energy in 2022 with 15 citations.

Efficacy of 2-Hydroxyflavanone in rodent models of pain and inflammation: involvement of opioidergic and GABAergic anti-nociceptive mechanisms

  • Published in Energy in 2022 with 12 citations.

Phytochemicals-based therapeutics against Alzheimer’s disease: an update

  • Published in Energy in 2022 with 11 citations.

Physicochemical and nanomedicine applications of phyto-reduced erbium oxide (Er2O3) nanoparticles

  • Published in Energy in 2023 with 8 citations.

Anabasis articulata (Forssk.) Moq: A Good Source of Phytochemicals with Antibacterial, Antioxidant, and Antidiabetic Potential

  • Published in Energy in 2022 with 8 citations.

 

Assoc Prof Dr. Mo’tasem Alsmadi | Biopharmaceutics

Posted on by ScienceFather
Assoc Prof Dr. Mo’tasem Alsmadi : Leading Researcher in Biopharmaceutics by Best Researcher Award

Associate Professor at Biopharmaceutics, Jordan University of Science & Technology, Jordan

Your remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.

🔬 Your successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.

🏆 The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.

Professional Profiles:

Education:

Dr. Motasem Alsmadi is an Associate Professor of Biopharmaceutics and Pharmacokinetics with a joint appointment between the Nanotechnology Institute and the Pharmaceutical Technology Department at Jordan University of Science and Technology (J.U.S.T). He earned his BSc in Pharmacy, ranking first in his class, from J.U.S.T in 2009. Subsequently, he pursued graduate studies in Pharmaceutical Technology at The University of Iowa, completing his Ph.D. in December 2014. Afterward, he worked as an Assistant Professor of Pharmaceutical Technology at the Pharmacy School at J.U.S.T until September 2020, during which time he also served as an Assistant Dean at the Pharmacy School and the Graduate Studies School.

In September 2020, Dr. Alsmadi was promoted to an Associate Professor, and in January 2023, he was appointed as a Joint Professor in the Nanotechnology Institute. In this capacity, he taught graduate-level courses and supervised master’s students at the Nanotechnology Institute, in addition to his involvement in teaching undergraduate (B.Sc and Pharm D.) and graduate (MSc and Ph.D.) courses and supervising master’s students at the Pharmacy School. Dr. Alsmadi also served as a member of the JFDA Bioavailability and Bioequivalence Committee for two years (10/2019-10/2021) as part of his national service.

Academic/Professional Particulars:

Dr. Motasem Alsmadi specializes in Pharmaceutics/Biopharmaceutics and Pharmacokinetics, as well as Nanomedicine and in vivo safety and toxicokinetics of drug delivery systems. His academic qualifications include a Ph.D. in Pharmaceutics from the University of Iowa, USA, awarded in 2014. His dissertation was titled “Physiologically based pharmacokinetic (PBPK) model of Ivermectin (IVM),” and he achieved a GPA of 3.84. Dr. Alsmadi also holds a BSc in Pharmacy from Jordan University of Science and Technology, Jordan, awarded in 2008, where he ranked 1st in his batch. In terms of academic honors and awards, Dr. Alsmadi ranked 1st in the 2003 batch of BSc. in Pharmacy at Jordan University of Science and Technology from 2003 to 2008.

Mo’tasem Alsmadi ‘s citation metrics and indices from Google Scholar are as follows:

  • Cited by: All: 208, Since 2018: 208
  • Citations: 208 (All), 208 (Since 2018)
  • h-index: 9 (All), 9 (Since 2018)
  • i10-index: 7 (All), 7 (Since 2018)

These metrics showcase the impact of Alsmadi ‘s work within the academic community, demonstrating the number of citations his publications have received and the influence of his research output.

Research:

Dr. Motasem Alsmadi’s research interests include Physiologically-based Pharmacokinetics, Biopharmaceutics and Pharmacokinetics, and Nanomedicine, with a focus on in vivo safety and toxicokinetics of drug delivery systems. In terms of publications and citations, he has authored 17 articles in international refereed journals and presented 2 conference papers. His work has garnered 147 citations on Google Scholar. Dr. Alsmadi has also been involved in securing research grants, including the Local University Fund for Master’s Thesis, where he serves as the Principal Investigator for the project “Formulation and evaluation of oral administration of cilnidipine nanocrystals for treatment of Hypertension diseases by enhancing solubility and dissolution rate” at Jordan University of Science and Technology (07/2023 – Present), with a funding of USD 7,700. Additionally, he has been a Co-Investigator for another project titled “Physiologically-Based Pharmacokinetics of a Novel Hydroxychloroquine Formulation Prepared Using Supercritical Fluid Technology for Pulmonary Administration” at Jordan University of Science and Technology (08/2021 – 01/2023), with a funding of USD 8,000.

Teaching:

Dr. Motasem Alsmadi has taught several courses, including Nano 700: Introduction to Nanoscience and Nanotechnology (taught once, excellent evaluation), Phar456: Bio Pharmaceutics and Pharmacokinetics (taught fourteen times, excellent evaluations), Phar 553: Clinical Pharmacokinetics (For Pharm D Students) (taught fifteen times, excellent evaluations), Phar401: Pharmaceutical Practical Training (taught three times, excellent evaluations), Phar 402: Community Pharmacy (For Pharm.D Students) (taught twice, excellent evaluations), and Phar 351: Pharmaceutics 1 (taught once, excellent evaluation). This demonstrates Dr. Alsmadi’s extensive experience in teaching a variety of pharmaceutical and pharmacokinetics courses, consistently earning high evaluations from his students.

Publications:

Preparation of hybrid alginate-chitosan aerogel as potential carriers for pulmonary drug delivery

  • Published in Energy in 2020 with 38 citations.

Development, In Vitro Characterization, and In Vivo Toxicity Evaluation of Chitosan-Alginate Nanoporous Carriers Loaded with Cisplatin for Lung Cancer Treatment

  • Published in Energy in 2020 with 34 citations.

Enhancement of the dissolution and bioavailability from freeze-dried powder of a hypocholesterolemic drug in the presence of Soluplus

  • Published in Energy in 2018 with 18 citations.

Pharmacy education in Jordan: updates

  • Published in Energy in 2017 with 17 citations.

Optimization of drugs pharmacotherapy during pregnancy using physiologically based pharmacokinetic models-an update

  • Published in Energy in 2018 with 14 citations.

Sublingual spray drug delivery of ketorolac-loaded chitosan nanoparticles

  • Published in Energy in 2018 with 14 citations.

 

Dr. Habtamu Endale | Veterinary Pharmacology

Posted on by ScienceFather
🎉🏆 Congratulations, Dr. Habtamu Endale, on Your Outstanding Achievement as the Best Researcher! 🏆🎉
Dr. Habtamu Endale : Leading Researcher in Veterinary Pharmacology

Lecturer and Researcher at Heat exchangers, Wolaita Sodo University ,Ethiopia

Your remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.

🔬 Your successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.

🏆 The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.

Professional Profiles:

RESEARCH, INNOVATIONS AND EXTENSION:

The research endeavors of our team have yielded fruitful outcomes, with a total of 10 research projects successfully completed and ongoing. Our scholarly impact is reflected in a citation index of 6 in renowned databases such as Scopus, Web of Science, and PubMed, along with 7 publications in journals indexed in SCI and SCIE. While our focus extends across diverse areas such as veterinary parasitology, animal biotechnology, virology, pathology, animal welfare, pharmacology, and vaccinology, we have yet to publish books with ISBN or engage in consultancy and industry-sponsored projects. The cumulative impact factor of our publications over the last 3 years underscores our commitment to high-quality research.

Although the number of patents published or under process is currently at zero, we have fostered collaborative activities through 10 joint publications and projects. Our research extends beyond borders, with scholars actively engaged in ongoing projects and one research scholar currently pursuing their studies. Regrettably, the number of countries visited for research activities remains at zero. However, our contribution to the academic community is evident in the publication of three journals indexed in Scopus, Web of Science, and PubMed.

Habtamu Endale citation metrics and indices from Google Scholar are as follows:

Cited by: All: 7, Since 2018: 7
Citations: 7 (All), 7 (Since 2018)
h-index: 1 (All), 1 (Since 2018)
i10-index: 0 (All), 0 (Since 2018)

PUBLICATIONS:

1.Study on prevalence of hard ticks and their associated risk factors in small ruminants of Boloso Sore districts of Wolaita zone, southern Ethiopia

  • Published in Energy Conversion and Management in 2021 with 5 citations.

2.Identification and estimation of the prevalence of ectoparasites of backyard chicken in Boloso Sore District, Wolaita zone, southern Ethiopia

  • Published in Energy Conversion and Management in 2023 with 1 citations.

3.Study on Seroprevalence and Associated Risk Factors of Newcastle Disease in Smallholder Poultry Farms in Sodo Zuria District, Wolaita Zone, Southern Ethiopia

  • Published in Energy Conversion and Management in 2022 with 1 citations.

4.Potential Causes of Spread of Antimicrobial Resistance and Preventive Measures in One Health Perspective-A Review

  • Published in Energy Conversion and Management in 2023 with 0 citations.

5.Coprological and postmortem assessment and economic significance of bovine fasciolosis in cattle slaughtered at Tarcha Municipal Abattoir, Southern Ethiopia

  • Published in Energy Conversion and Management in 2023 with 0 citations.

 

Assist Prof Dr. Omaish Alqahtani | Pharmacognosy

Posted on by ScienceFather
🎉🏆 Congratulations,Assist Prof Dr. Omaish Alqahtani, on Your Outstanding Achievement as the Best Researcher! 🏆🎉
Assist Prof Dr. Omaish  Alqahtani : Leading Researcher in Pharmacognosy

Congratulations, Prof Dr. Omaish  Alqahtani, on winning the esteemed Best Researcher Award from Sciencefather! Your dedication, innovative research, and scholarly contributions have truly made a significant impact in your field. Your commitment to advancing knowledge and pushing the boundaries of research is commendable. Here’s to your continued success in shaping the future of academia and making invaluable contributions to your field. Well done!

Assist Prof Dr. Omaish Alqahtani, a distinguished academic and researcher in the field of renewable energy, holds a Assistant professor in Pharmacognosy from Najran University, Saudi Arabia. His academic journey has been marked by a profound dedication to advancing solar energy technologies, specifically in solar thermal harvesting and its integration into agricultural and architectural applications.

Professional Experiences

❖ Assistant Professor (2022 – present)

  • College of Pharmacy, Najran University, Najran, Saudi Arabia

❖ Lecturer (2017 – 2022)

  • College of Pharmacy, Najran University, Najran, Saudi Arabia

❖ Teaching Assistant (2011 – 2017)

  • College of Pharmacy, Najran University, Najran, Saudi Arabia

❖ Pharmacist (10/2010 – 1/2011)

  • King Fahad Central Hospital, Jazan, Saudi Arabia

Committee Memberships

❖ Head of the Teaching and Learning Unit (2022 – present)

❖ Head of the E-Learning Unit (2022 – present)

❖ Member of the Annual Report Committee (2022 – present)

❖ Member of the Field Training and Alumni Unit (2021 – present)

❖ Head of the Training and Scholarship Unit (2021 – 2023)

❖ Member of the Scientific Research Unit (2021 – 2023)

❖ Member of the Student Activities Unit (2022 – 2023)

Teaching Experiences

  • Recent Approaches in Medicinal plants analysis.
  • Herbal and Alternative Medicine.
  • Pharmacognosy (2).
  • Pharmacognosy (1) – Practical.

Education

❖ PhD in Pharmacognosy (2021)

  • School of Pharmacy, University College London, London, United Kingdom.

❖ MSc in Pharmacognosy (2015)

  • School of Pharmacy, University College London, London, United Kingdom.

❖ BSc in Pharmaceutical Sciences (2010)

  • College of Pharmacy, King Khalid University, Abha, Saudi Arabia.

Scientific Societies

❖ Member of the American Society of Pharmacognosy.

❖ Member of the Society of Medicinal Plant and Natural Products.

❖ Member of the Phytochemical Society of Europe.

Research Interest

❖ Discovering novel bioactive compounds from plants and bacteria.

Research List

  1. Design, Characterization, and Antimicrobial Evaluation of Copper Nanoparticles Utilizing Tamarixinin, an Ellagitannin from Galls of Tamarix aphylla.
  2. Phytochemistry, anti-diabetic and antioxidant potentials of Allium consanguineum Kunth.
  3. Synergistic Effect between Amoxicillin and Zinc Oxide Nanoparticles Reduced by Oak Gall Extract Against Helicobacter pylori.
  4. In Vitro Antibacterial Activity of Green Synthesized Silver Nanoparticles Using Azadirachta indica Aqueous Leaf Extract against MDR Pathogens.
  5. Characterization and isolation of the major biologically active metabolites isolated from Ficus retusa and their synergistic effect with Tetracycline against certain pathogenic-resistant Bacteria.
  6. The Biosynthesized Zinc Oxide Nanoparticles’ Antiviral Activity in Combination with Pelargonium zonale Extract against the Human Corona 229E Virus.
  7. Human Lung Cancer (A549) Cell Line Cytotoxicity and Anti-Leishmania major Activity of Carissa macrocarpa Leaves: A Study Supported by UPLCESI-MS/MS Metabolites Profiling and Molecular Docking.
  8. Phytochemical fingerprint and biological activities of three Malaysian Ficus Deltoidea Cultivars.
  9. Production of antibacterial compounds using Bacillus spp. isolated from thermal springs in Saudi Arabia.
  10. Quantitative-HPLC-DAD polyphenols analysis, anxiolytic and cognition enhancing potentials of Sorbaria tomentosa Lindl. Rehder.
  11. Process optimization, antioxidant, antibacterial, drug adjuvant properties of bioactive keratin microparticles derived from porcupine (Hystrix indica) quills.
  12. Nutritional, Antioxidant, Antimicrobial, and Anticholinesterase Properties of Phyllanthus emblica: A Study Supported by Spectroscopic and Computational Investigations.